Serum and Aqueous Humor miR-199a-3p and FN1 Levels Correlate with Type 2 Diabetic Retinopathy Severity

Overview

This study identifies a significant association between decreased miR-199a-3p and increased FN1 expression in serum and aqueous humor with the severity of type 2 diabetic retinopathy (DR) in a Chinese cohort. Bioinformatics and clinical sample analyses reveal that miR-199a-3p and FN1 may serve as potential biomarkers and therapeutic targets for DR progression.

Background

Diabetic retinopathy (DR) is a leading cause of visual impairment in working-age adults, driven by chronic hyperglycemia-induced neurovascular damage. Early diagnosis and effective prevention remain challenging, highlighting the need for sensitive biomarkers. MicroRNAs (miRNAs), particularly miR-199a-3p, and extracellular matrix components like fibronectin 1 (FN1) have emerged as key regulators in DR pathogenesis but require further elucidation. This study integrates bioinformatics and clinical validation to explore the expression and interaction of miR-199a-3p and FN1 in DR.

Data Highlights

Key Findings

• miR-199a-3p expression is significantly downregulated in serum and aqueous humor of patients with DR compared to controls.
• FN1 expression is significantly upregulated in serum and aqueous humor correlating with DR severity.
• Bioinformatics analysis identified FN1 as a key target gene of miR-199a-3p involved in DR pathogenesis.
• miR-199a-3p modulates angiogenesis via the PI3K/AKT pathway by targeting VEGF, influencing retinal microvascular endothelial cell behavior.
• Combined expression profiles of miR-199a-3p and FN1 may serve as sensitive biomarkers for early diagnosis and monitoring of DR progression.

Clinical Implications

Measurement of miR-199a-3p and FN1 levels in serum and aqueous humor could enhance early detection and severity assessment of diabetic retinopathy. Targeting the miR-199a-3p/FN1 regulatory axis may offer novel therapeutic strategies to inhibit pathological angiogenesis and fibrosis in DR, potentially improving patient outcomes.

Conclusion

The study demonstrates that altered expression of miR-199a-3p and FN1 is closely associated with the severity of type 2 diabetic retinopathy, supporting their roles as promising biomarkers and therapeutic targets. Integrating molecular profiling with clinical evaluation may advance early diagnosis and precision treatment of DR.

Related Resources & Content

1. GSE102485 and GSE60436 GEO datasets -- Gene Expression Omnibus
2. Preliminary studies on miR-199a-3p and VEGF in DR -- Unpublished data